Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 21 results found. Search for [ hepatitis C virus ]

Results 1 to 21 of 21
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar
November 12, 2020
Zydus Cadila's Pegylated Interferon alpha-2b, PegiHep, was originally approved for Hepatitis C and was launched in the Indian market in 2011; it was repurposed for treating moderate COVID-19 patients


Anshula Raj
November 12, 2020
Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India


PTI
November 12, 2020
Zydus Cadila said its Pegylated Interferon alpha-2b, PegiHep, was originally approved for Hepatitis C and was launched in the Indian market in 2011


Reuters
October 14, 2020
While severe COVID-19 symptoms are extremely rare in infected children, they can pass on the virus to high-risk groups such as the elderly


Reuters
October 6, 2020
Scientists Roger Penrose, Reinhard Genzel and Andrea Ghez won the 2020 Nobel Prize for Physics for their discoveries about the black hole


Reuters
October 5, 2020
\"Prior to their work, the discovery of the Hepatitis A and B viruses had been critical steps forward,\" the Nobel Assembly at Sweden's Karolinska Institute said in a statement on awarding the prize of 10 million Swedish crowns ($1.1 million)


Associated Press
September 25, 2020
Stringent regulations in the U.S., European Union, Japan and Australia have historically blocked the sale of Chinese vaccines


BusinessToday.In
July 27, 2020
More than 5 lakh tests are being conducted in the country daily, efforts are underway to increase this capacity to 10 lakh in the coming weeks, says PM Modi


PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally


BusinessToday.In
New Delhi, May 14, 2020
Coronavirus crisis: Jim Collins who started working on virus sensors at his bioengineering laboratory in 2014 was crafting a technology that could detect the Zika virus. Now, they are reworking the technology to identify COVID-19


PB Jayakumar
May 11, 2020
Mumbai-based medical devices company Transasia Biomedical's German subsidiary Erba Mannheim has already got clearance from the US and Europe to make COVID-19 antibody ELISA kits


PTI
May 5, 2020
The results are also supported by the fact that both SARS-CoV-2 and the hepatitis C virus are a virus of the same type, a so-called single-stranded RNA virus, explained Efferth


Satish Reddy
February 28, 2020
The Indian pharmaceutical industry has taken robust strides in ensuring the highest possible standards in quality and efficacy of medicines at affordable costs to patients


Joe C Mathew
February 22, 2020
Ever since India changed its intellectual property laws in 2005 to permit product patents in India, the country has been increasingly granting patents


PTI
February 24, 2019



PTI
November 26, 2018



E Kumar Sharma
New Delhi, November 14, 2018
Hepatitis B and C are known as silent ailments with no early symptoms, but timely tests can prevent long-term damage.


PB Jayakumar
December 30, 2015
Year 2015 should be regarded as a good year for patients worldwide as the USFDA has given approvals for 45 New Molecular Entity and New Therapeutic Biological Products.


E. Kumar Sharma
November 4, 2012
India's Intellectual Property Appellate Board has revoked the patent granted in India to F. Hoffmann-La Roche AG (Roche) for pegylated interferon alfa-2a, a medicine used to treat hepatitis C, citing lack of evidence that the drug was better than existing treatments available in the market.


PAGES 1 OF 2  12